These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32216735)

  • 21. Vancomycin-intermediate Staphylococcus epidermidis: curio or omen?
    Strausbaugh LJ
    Infect Control Hosp Epidemiol; 1999 Mar; 20(3):163-5. PubMed ID: 10100540
    [No Abstract]   [Full Text] [Related]  

  • 22. Reduced susceptibility to vancomycin and biofilm formation in methicillin-resistant Staphylococcus epidermidis isolated from blood cultures.
    Pinheiro L; Brito CI; Pereira VC; Oliveira Ad; Camargo CH; Cunha Mde L
    Mem Inst Oswaldo Cruz; 2014 Nov; 109(7):871-8. PubMed ID: 25410990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dosing and monitoring of vancomycin: what is the best way forward?
    Drennan PG; Begg EJ; Gardiner SJ; Kirkpatrick CMJ; Chambers ST
    Int J Antimicrob Agents; 2019 Apr; 53(4):401-407. PubMed ID: 30599240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between trough concentration of vancomycin and effect on methicillin-resistant Staphylococcus aureus in critically ill patients.
    Cheong JY; Makmor-Bakry M; Lau CL; Abdul Rahman R
    S Afr Med J; 2012 May; 102(7):616-9. PubMed ID: 22748440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Vancomycin resistant Staphylococcus epidermidis caused prosthesis infection. Linezolid and rifampicin healed the complicated infection].
    Håkanson A; Fröding I; Ottosson C
    Lakartidningen; 2014 Feb; 111(9-10):396-8. PubMed ID: 24570136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vancomycin drug monitoring in infants with CoNS sepsis-target attainment, microbiological response and nephrotoxicity.
    Viel-Thériault I; Martin B; Thompson-Desormeaux F; Blackburn J; Moussa A; Autmizguine J
    J Perinatol; 2020 Jan; 40(1):97-104. PubMed ID: 31576000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changing the Time of Blood Collection to Determine Vancomycin Concentrations in Intensive Care Unit Patients.
    Hammond DA; James TB; Atkinson LN; Painter JT; Lusardi K
    Crit Care Nurse; 2018 Feb; 38(1):24-28. PubMed ID: 29437075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.
    Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M
    Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro inhibition of coagulase-negative staphylococci by vancomycin/aminoglycoside-loaded cement spacers.
    Streuli JC; Exner GU; Reize CL; Merkofer C; Scott CP; Zbinden R
    Infection; 2006 Apr; 34(2):81-6. PubMed ID: 16703297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients.
    Abdel Hadi O; Al Omar S; Nazer LH; Mubarak S; Le J
    J Oncol Pharm Pract; 2016 Jun; 22(3):448-53. PubMed ID: 26079639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Peritonitis due to glycopeptides-resistant Staphylococcus epidermidis].
    Watine J; Ciobotaru M; Lombart D; Thomas K; Amirou M
    Ann Biol Clin (Paris); 2010; 68(1):99-103. PubMed ID: 20146979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility Profile of Staphylococcus epidermidis and Staphylococcus haemolyticus Isolated from Blood Cultures to Vancomycin and Novel Antimicrobial Drugs over a Period of 12 Years.
    Pinheiro L; Brito CI; Pereira VC; Oliveira A; Bartolomeu AR; Camargo CH; Cunha ML
    Microb Drug Resist; 2016 Jun; 22(4):283-93. PubMed ID: 26623676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of ceftaroline versus vancomycin in an experimental foreign-body and systemic infection model caused by biofilm-producing methicillin-resistant Staphylococcus epidermidis.
    Domínguez-Herrera J; López-Rojas R; Smani Y; Labrador-Herrera G; Pachón J
    Int J Antimicrob Agents; 2016 Dec; 48(6):661-665. PubMed ID: 28128094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vancomycin serum concentrations in pediatric oncologic/hematologic intensive care patients.
    Silva DC; Seixas GT; Araujo OR; Arduini RG; Carlesse FA; Petrilli AS
    Braz J Infect Dis; 2012; 16(4):361-5. PubMed ID: 22846125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
    Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
    Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association Between Vancomycin Trough Concentrations and Duration of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children.
    Hsu AJ; Hamdy RF; Huang Y; Olson JA; Ghobrial S; Gerber JS; Hersh AL; Tamma PD
    J Pediatric Infect Dis Soc; 2018 Dec; 7(4):338-341. PubMed ID: 28992126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are Vancomycin Trough Concentrations of 15 to 20 mg/L Associated With Increased Attainment of an AUC/MIC ≥ 400 in Patients With Presumed MRSA Infection?
    Hale CM; Seabury RW; Steele JM; Darko W; Miller CD
    J Pharm Pract; 2017 Jun; 30(3):329-335. PubMed ID: 27074786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Optimal vancomycin serum level in Staphylococcus aureus infections?].
    Bingen E; Mariani-Kurkdjian P; Nebbad B
    Med Mal Infect; 2006 Sep; 36(9):439-42. PubMed ID: 17027219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of a Vancomycin Pharmacokinetic Model and Trough Serum Concentrations in Pediatric Patients.
    Ploessl C; White C; Manasco K
    Pediatr Infect Dis J; 2015 Oct; 34(10):e244-7. PubMed ID: 26121203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of linezolid on staphylococcal adherence versus time of treatment.
    Pagano PJ; Buchanan LV; Dailey CF; Haas JV; Van Enk RA; Gibson JK
    Int J Antimicrob Agents; 2004 Mar; 23(3):226-34. PubMed ID: 15164962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.